Search alternatives:
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11021
dPRPS plays a critical function during cellular response to oxidative stress.
Published 2019“…<p>(A) Ovaries (upper panel) or fat bodies (lower panel) of adult <i>dPRPS GFP-trap</i> flies fed with PBS or PQT are immunostained for GFP (green) and DAPI (blue). …”
-
11022
B[a]P treatment results in modulation of intracellular phosphop38 MAP kinase.
Published 2010“…Similarly, phosphoP38 MAP kinase level in 0.2 µM B[a]P treated group after 24 h, was significantly decreased as compared to that in 12 h post treatment group. …”
-
11023
Blockade of Alk receptor activation abolishes neuronal differentiation due to Activin A treatment.
Published 2012“…Co-treatment with Activin A and SB431542 or Activin A plus Follistatin decreased to the half mRNA expression for neuronal markers, while increased GFAP expression. …”
-
11024
Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis
Published 2016“…In a subgroup analysis by flavonoid subtypes, the ovarian cancer risk was also decreased for isoflavones (<i>RR</i> = 0.67, 95% CI = 0.50–0.92) and flavonols (<i>RR</i> = 0.68, 95% CI = 0.58–0.80). …”
-
11025
Impact of mepolizumab in patients with high-burden severe asthma within a managed care population
Published 2023“…Of the 264 patients with ≥1 OCS claim during baseline, 191 (72.3%) showed a decrease in mean daily OCS use by ≥50% in 117 patients (61.3%). …”
-
11026
Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention
Published 2018“…It increases urinary excretion of magnesium and potassium caused a significant decrease in urinary oxalate and uric acid in patients with hyperoxaluria and hyperuricosuria. …”
-
11027
Raw data.
Published 2025“…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
-
11028
-
11029
Baseline characteristics of the subjects.
Published 2025“…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
-
11030
Knockdown of nr2f1a causes defects in zebrafish vascular development.
Published 2014“…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a ∼50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
-
11031
Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies
Published 2014“…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
-
11032
Table 1_Obinutuzumab in systemic lupus erythematosus: a real-world experience.docx
Published 2025“…Objectives<p>To describe the real-world efficacy and safety of obinutuzumab in a heterogeneous systemic lupus erythematosus (SLE) population, including severe or refractory manifestations.…”
-
11033
-
11034
-
11035
S2 Data -
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
11036
Study protocol.
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
11037
S1 Data -
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
11038
-
11039
-
11040